Skip to main content
SpringerLink
Log in

Drug Therapy of Non-Insulin-Dependent Diabetes Mellitus in the Elderly

  • Disease Management
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Non-insulin-dependent diabetes (NIDDM) is a common problem in the elderly. The discovery of several classes of oral antidiabetic agents has increased the prospects of achieving better control of hyperglycaemia with reduced risk of severe adverse events. Some of these agents, such as acarbose or miglitol, do not cause hypoglycaemia and act locally in the gut. As such they are safer agents. On the other hand, the low cost of some sulphonylurea agents and a once or twice daily administration schedule make them an attractive option. Metformin appears to be especially useful in obese insulin-resistant patients with NIDDM. However, obesity is not as much of a problem in the elderly as it is in middle-aged patients, and contraindications to the use of metformin are common in the elderly. The use of a combination of 2 or 3 oral antidiabetic agents to delay the need for insulin therapy is now possible. The long term effects of this approach are not known and the cost of polypharmacy is of concern.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Morley JE, Mooradian AD, Rosenthal MJ, et al. Diabetes mellitus in elderly patients: is it different?. Am J Med 1987; 83: 533–44

    Article  PubMed  CAS  Google Scholar 

  2. Mooradian AD. Management of diabetes in elderly. In: Morley JE, Korenman SG, editors. Endocrinology and metabolism in the elderly. Boston: Blackwell Scientific Publications, 1992: 388–405

    Google Scholar 

  3. Harris MI, Hadden WC, Knowler WC, et al. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20–74 years. Diabetes 1987; 38: 523–34

    Google Scholar 

  4. Rosenthal MJ, Morley JE. Diabetes and its complications in older people. In: Morley JE, Korenman SG, editors. Endocrinology and metabolism in the elderly. Boston (MA): Black-well Scientific Publications, 1992: 373–87

    Google Scholar 

  5. Ferner RE. Oral hypoglycemic agents. Med Clin North Am 1988; 72: 1323–35

    PubMed  CAS  Google Scholar 

  6. Melander A, Bitzen PO, Faber O, et al. Sulfonylurea antidiabetic drugs: an update of their clinical pharmacology and rational therapeutic use. Drugs 1989; 37: 58–72

    Article  PubMed  CAS  Google Scholar 

  7. Gerich JE. Oral hypoglycemic agents. N Engl J Med 1989; 321: 1231–45

    Article  PubMed  CAS  Google Scholar 

  8. Groop L. Sulfonylureas in NIDDM. Diabetes Care 1992; 18: 737–54

    Article  Google Scholar 

  9. Mooradian AD. The effect of sulfonylureas on the in vivo tissue uptake of glucose in normal rats. Diabetologia 1987; 30: 120–1

    PubMed  CAS  Google Scholar 

  10. Campbell IW. Sulfonylureas and metformin: efficacy and inadequacy. In: Bailey CJ, Flatt PR, editors. New antidiabetic drugs. London: Smith, Gordon, Nishimura, 1990: 33–51

    Google Scholar 

  11. Krall LP. The treatments of NIDDM in the decade of 90s. Diabetes Res Clin Pract 1991; 14 Suppl. 2: 515–9

    Google Scholar 

  12. Lebovitz HE. Are oral hypoglycemic agents likely to benefit NIDDM patients?. Hosp Pract 1992; 27 Suppl. 1: 26–31

    Google Scholar 

  13. Ziegler O, Drouin P. Hemobiological activity of gliclazide in diabetes mellitus. Diabetes Res Clin Pract 1991; 14 Suppl. 2: 583–9

    Google Scholar 

  14. Lebovitz HE, Pasmantier R. Combination insulin-sulfonylurea therapy. Diabetes Care 1990; 13: 667–75

    Article  PubMed  CAS  Google Scholar 

  15. Berelowitz M, Fischette C, Cefalu W, et al. Comparative efficacy of a once daily controlled release formulation of glipizide and immediate-release glipizide in patients with NIDDM. Diabetes Care 1994; 17: 1460–4

    Article  PubMed  CAS  Google Scholar 

  16. Jennings AM, Wilson RM, Ward JD. Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents. Diabetes Care 1989; 12: 203–8

    Article  PubMed  CAS  Google Scholar 

  17. United Kingdom Prospective Diabetes Study Group. United Kingdom Prospective Diabetes Study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 1995; 310: 83–8

    Article  Google Scholar 

  18. Berger W. Incidence of severe side effects during therapy with sulfonylureas and biguanides. Horm Metab Res 1985; 15 Suppl.: 111–5

    CAS  Google Scholar 

  19. Campbell IW. Metformin and the sulfonylureas: the comparative risk. Horm Metab Res 1985; 15 Suppl.: 105–11

    CAS  Google Scholar 

  20. Asplund K, Wilholm B-E, Lithner F. Glibenclamide associated hypoglycemia: a report on 57 cases. Diabetologia 1983; 24: 412–7

    Article  PubMed  CAS  Google Scholar 

  21. Asplund K, Wilholm B-E, Lundman B. Severe hypoglycemia during treatment with glipizide. Diabet Med 1991; 8: 726–31

    Article  PubMed  CAS  Google Scholar 

  22. Ferner RE, Neil HAW. Sulfonylureas and hypoglycemia. BMJ 1988; 296: 949–50

    Article  PubMed  CAS  Google Scholar 

  23. Baily CJ. Biguanides and NIDDM. Diabetes Care 1992; 15: 755–72

    Article  Google Scholar 

  24. Wu MS, Johnston P, Shew WHH, et al. Effect of metformin on carbohydrate lipoprotein metabolism in NIDDM patients. Diabetes Care 1990; 13: 1–8

    Article  PubMed  CAS  Google Scholar 

  25. Perriello G, Misericordia P, Volpi E, et al. Acute antihyperglycemic mechanisms of metformin in NIDDM: evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes 1994; 43: 920–8

    Article  PubMed  CAS  Google Scholar 

  26. Stumvoll M, Nurjhan N, Perriello G, et al. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333: 550–4

    Article  PubMed  CAS  Google Scholar 

  27. Bailey CJ. Metformin: an update. Gen Pharmacol 1993; 24: 1299–309

    Article  PubMed  CAS  Google Scholar 

  28. Bailey CJ, Nattrass M. Treatment — metformin. Baillieres Clin Endocrinol Metab 1988; 2: 455–76

    Article  PubMed  CAS  Google Scholar 

  29. Bailey CJ, Lord JM, Atkins TW. The insulin receptor and diabetes. In: Nattrass M, Santiago JV, editors. Recent advances in diabetes. Edinburgh: Churchill Livingstone, 1984: 27–44

    Google Scholar 

  30. Klip A, Sarabia V, Ramlal T, et al. Glucose transport in human muscle cells in culture: stimulation by insulin and metformin [abstract]. Diabetes 1990; 39 Suppl. 1: 82A

    Google Scholar 

  31. Sirtori CR, Franceshini G, Gianfranschi G, et al. Metformin improves peripheral vascular flow in non-hyperlipidemic patients with arterial disease. J Cardiovasc Pharmacol 1984; 6: 914–23

    Article  PubMed  CAS  Google Scholar 

  32. Vague P, Juhan-Vague I, Alessi MC, et al. Metformin decreases the high Plasminogen activator capacity plasma insulin and triglyceride levels in non-diabetic obese subjects. Thromb Haemost 1987; 57: 326–8

    PubMed  CAS  Google Scholar 

  33. DeFronzo RA, Goodman AM and the Multicenter Metformin Study Group. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333: 541–9

    Article  PubMed  CAS  Google Scholar 

  34. Mooradian D, Kalis J, Nugent CA. The nutritional status of ambulatory elderly type II diabetic patients. Age 1990; 13: 87–9

    Article  Google Scholar 

  35. Mooradian AD, Osterweil D, Petrasek D, et al. Diabetes mellitus in elderly nursing home patients: a survey of clinical characteristics and management. J Am Geriatr Soc 1988; 36: 391–6

    PubMed  CAS  Google Scholar 

  36. Reed RL, Mooradian AD. Nutritional status and dietary management of elderly diabetic patients. Clin Geriatr Med 1990; 6: 883–901

    PubMed  CAS  Google Scholar 

  37. Dandona P, Fonseca V, Mier A, et al. Diarrhea and metformin in a diabetic clinic. Diabetes Care 1983; 6: 472–4

    Article  PubMed  CAS  Google Scholar 

  38. Tomkin G. Malabsorption of vitamin B12 in diabetic patients treated with phenformin: a comparison with metformin. BMJ 1973; III: 673–5

    Article  Google Scholar 

  39. Bergman U, Boman G, Wilholm BE. Epidemiology of adverse drug reactions to phenformin and metformin. BMJ 1978; II: 464–466

    Article  Google Scholar 

  40. Nattrass M, Alberti KGMM. Biguanides. Diabetologia 1978; 14: 71–4

    Article  PubMed  CAS  Google Scholar 

  41. Jenkins DJA, Taylor RH, Goff DJ, et al. Scope and specificity of acarbose in slowing carbohydrate absorption in man. Diabetes 1981; 30: 951–4

    Article  PubMed  CAS  Google Scholar 

  42. Clissold SP, Edwards C. Acarbose: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1988; 35: 214–43

    Article  PubMed  CAS  Google Scholar 

  43. Hollander P. Safety profile of acarbose, an α-glucosidase inhibitor. Drugs 1990; 44 Suppl. 3: 47–53

    Google Scholar 

  44. Chaisson J-L, Josse RG, Hunt JA, et al. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. Ann Intern Med 1994; 121: 928–35

    Google Scholar 

  45. Hoffman J, Spengler M. Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM. Diabetes Care 1994; 17: 561–6

    Article  Google Scholar 

  46. Kosaka K, Kuzuya T, Akanuma Y, et al. Clinical evaluation of a new oral hypoglycemic drug CS-045 in patients with non-insulin dependent diabetes mellitus poorly controlled by diet alone: a double-blind placebo controlled study. J Clin Ther Med 1993; 9 Suppl. 3: 61–93

    Google Scholar 

  47. Kosaka K, Kuzuya T, Akanuma Y, et al. Clinical evaluation of a new hypoglycemic drug CS-045 in patients with non-insulin dependent diabetes mellitus poorly controlled by sulfonylureas: a double-blind placebo, controlled study. J Clin Ther Med 1993; 9 Suppl. 3: 95–126

    Google Scholar 

  48. Akanuma Y, Kosaka K, Kuzuya K, et al. Long term study of a new oral hypoglycemic agent CS-045 in patients with non-insulin dependent diabetes mellitus. J Clin Ther Med 1993; 9 Suppl. 3: 127–49

    Google Scholar 

  49. Suter SL, Nolan JJ, Wallace P, et al. Metabolic effects of a new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care 1992; 15: 193–203

    Article  PubMed  CAS  Google Scholar 

  50. Gutniak M, Orskov C, Holst JJ, et al. Antidiabetogenic effect of glucagon like peptide-1 (7–36) amide in normal subjects and patients with diabetes mellitus. N Engl J Med 1992; 326: 1316–22

    Article  PubMed  CAS  Google Scholar 

  51. Thompson RG, Gottlieb AB, Organ K, et al. The human amylin analogue (AC137) reduces glucose following sustacal in patients with Type II diabetes [abstract]. Diabetes 1995; 44: 127A

    Article  Google Scholar 

  52. Howey DC, Bowsher RR, Brunelle RL, et al. [Lys (B28), pro (B29)]- human insulin: a rapidly absorbed analogue of human insulin. Diabetes 1994; 43: 396–402

    Article  PubMed  CAS  Google Scholar 

  53. Mooradian AD, Failla M, Hoogwerf B, et al. Selected vitamins and minerals in diabetes. Diabetes Care 1994; 17: 464–79

    PubMed  CAS  Google Scholar 

  54. Knuiman MW, Welborn TA, McCann VJ, et al. Prevalence of diabetic complications in relation to risk factors. Diabetes 1986; 35: 1332–9

    Article  PubMed  CAS  Google Scholar 

  55. Campbell S, Mooradian AD. Diabetes mellitus. In: Bressler R, Katz MD, editors. Geriatric pharmacology. New York: McGraw Hill Inc., 1993: 409–25

    Google Scholar 

  56. Hermann LS, Schersten B, Bitzen P-O, et al. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations: a double blind controlled study. Diabetes Care 1994; 17: 1100–9

    Article  PubMed  CAS  Google Scholar 

  57. Mooradian AD. Biological and functional definition of the older patient: the role of biomarkers of aging. Oncology 1992; 6 Suppl.: 39–44

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The St Louis V.A. Medical Center and the Division of Endocrinology, Department of Internal Medicine, St Louis University School of Medicine, 1402 S. Grand Blvd, St Louis, Missouri, 63104, USA

    Arshag D. Mooradian

Authors
  1. Arshag D. Mooradian
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mooradian, A.D. Drug Therapy of Non-Insulin-Dependent Diabetes Mellitus in the Elderly. Drugs 51, 931–941 (1996). https://doi.org/10.2165/00003495-199651060-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199651060-00002

Keywords

Search

Navigation